Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[IgA linear dermatosis (author's transl)].

S Jablonska, T Chorzelski

    Annales De Dermatologie Et De Venereologie
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    IgA linear dermatosis is a distinct blistering disease characterized by linear IgA deposits. It differs from dermatitis herpetiformis and bullous pemphigoid, responding well to specific treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytokines may favor a role for human papillomaviruses in the pathogenesis of psoriasis.

    Archives of dermatology·2001
    Same author

    Bullous disorders: from histology to molecular biology.

    Clinics in dermatology·2001
    Same author

    Lupus erythematosus. What's new?

    Journal of the European Academy of Dermatology and Venereology : JEADV·2001
    Same author

    The use of two substrates for indirect immunofluorescence in the diagnosis of pemphigus.

    The British journal of dermatology·2001
    Same author

    Familial occurrence of scleroderma.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2001
    Same author

    Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses.

    Journal of virology·2001
    Same journal

    2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

    Annales de dermatologie et de venereologie·2026
    Same journal

    Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

    Annales de dermatologie et de venereologie·2026
    Same journal

    2024 recommendations for the therapeutic management of anogenital warts.

    Annales de dermatologie et de venereologie·2026
    Same journal

    Successful use of thalidomide in treating metastatic Crohn's disease.

    Annales de dermatologie et de venereologie·2026
    Same journal

    Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

    Annales de dermatologie et de venereologie·2026
    Same journal

    Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

    Annales de dermatologie et de venereologie·2026
    See all related articles

    Area of Science:

    • Immunodermatology
    • Autoimmune blistering diseases
    • Mucocutaneous disorders

    Context:

    • Distinguishing rare autoimmune blistering diseases from common forms like dermatitis herpetiformis (DH) and bullous pemphigoid (BP) is crucial for effective management.
    • Some cases present with overlapping clinical, histological, and ultrastructural features of both DH and BP.
    • Linear continuous IgA deposits along the basement membrane zone (BMZ) are a key diagnostic marker.

    Purpose:

    • To define IgA linear dermatosis as a distinct clinical entity.
    • To differentiate it from dermatitis herpetiformis and bullous pemphigoid based on diagnostic features.
    • To highlight the diagnostic significance of linear IgA deposits and propose nomenclature for adult and childhood forms.

    Summary:

    • IgA linear dermatosis is characterized by linear IgA deposits at the BMZ, differentiating it from DH's granular IgA deposits.

    Related Experiment Videos

  • Unlike DH, it lacks gluten-sensitive enteropathy and does not respond to a gluten-free diet.
  • IgA anti-BMZ antibodies may be present, but circulating IgG anti-BMZ antibodies are absent.
  • The condition, including its childhood counterpart (chronic bullous disease of childhood), responds favorably to low-dose sulfones and corticosteroids.

    • Impact:

    • Establishes IgA linear dermatosis as a distinct diagnostic entity, improving patient care.
    • Clarifies diagnostic criteria, aiding in differentiating it from DH and BP.
    • Informs treatment strategies, leading to better therapeutic outcomes with combined sulfone and corticosteroid therapy.
    • Proposes unified nomenclature (IgA linear dermatosis) for adult and childhood forms, enhancing clinical communication.